United Kingdom · Question · Written question
UIN 931
Sotrovimab
Original
Introduced
11 May 2022
Last action
17 May 2022 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
17 May 2022
Summary
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) availability and (b) accessibility of Sotrovimab in (i) Slough and (ii) England.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
11 May 2022
Written question
To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) availability and (b) accessibility of Sotrovimab in (i) Slough and (ii) England.
Source: Commons
17 May 2022
Answer
Patient access to sotrovimab is clinically determined in line with the published clinical access policies. Individuals at highest risk from COVID-19 infection can access this treatment directly from COVID Medicines Delivery Units (CMDUs) or via the RECOVE...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2022-05-11/931
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1462200
- uk · wq-1462200 · source updated 17 May 2022